XOM Stock Analysis: Exxon Mobil | NYSE
Oil & Gas Integrated | NYSE, USA | Market Cap: 692.857m USD | 12M Return: 66.5% | US30233Q1085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.02B
EPS Trend: -82.4%
Qual. Beats: -1
Rev. Trend: -10.7%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ExxonMobil Holdings Corporation (NYSE: XOM) is a U.S.-based integrated oil and gas major headquartered in Spring, Texas, with roots dating back to 1870. The company operates across four core segments: Upstream (exploration and production of crude oil and natural gas), Energy Products (fuels, aromatics, catalysts, and licensing), Chemical Products (olefins, polyolefins, and intermediates), and Specialty Products (lubricants, basestocks, waxes, synthetics, elastomers, and resins). It also manufactures, trades, transports, and sells crude oil, natural gas, petroleum products, and petrochemicals globally, with operations spanning the U.S., Canada, and international markets. Its products are marketed under the well-established Exxon, Esso, and Mobil brands, and it also supplies aviation fuel.
The company is increasingly pursuing lower-emission opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, Proxxima resin systems, carbon materials, low-carbon data center initiatives, and lithium-reflecting a strategic push to diversify beyond traditional hydrocarbons. As a mega-cap integrated oil and gas company, ExxonMobils business model spans the full petroleum value chain, from upstream extraction to downstream refining, chemicals, and specialty products, which typically provides diversification across commodity price cycles. The company recently rebranded from Exxon Mobil Corporation to ExxonMobil Holdings Corporation in July 2026.
- Crude oil prices swing on OPEC+ supply and demand outlook
- Pioneer acquisition accelerates Permian basin production growth
- Refining margins compress as global fuel demand weakens
| Net Income: 32.8b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.07 > 1.0 |
| NWC/Revenue: 3.31% < 20% (prev 5.15%; Δ -1.83% < -1%) |
| CFO/TA 0.13 > 3% & CFO 59.7b > Net Income 32.8b |
| Net Debt (38.1b) to EBITDA (71.8b): 0.53 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.17b) vs 12m ago -3.63% < -2% |
| Gross Margin: 25.15% > 18% (prev 22.49%; Δ 2.66% > 0.5%) |
| Asset Turnover: 79.17% > 50% (prev 73.59%; Δ 5.58% > 0%) |
| Interest Coverage Ratio: 52.13 > 6 (EBIT TTM 42.2b / Interest Expense TTM 809.0m) |
| A: 0.03 (Total Current Assets 101b - Total Current Liabilities 88.8b) / Total Assets 464b |
| B: 1.06 (Retained Earnings 493b / Total Assets 464b) |
| C: 0.09 (EBIT TTM 42.2b / Avg Total Assets 456b) |
| D: 1.31 (Book Value of Equity 259b / Total Liabilities 198b) |
| Altman-Z'' = 5.62 = AAA |
| DSRI: 1.32 (Receivables 60.6b/41.8b, Revenue 361b/329b) |
| GMI: 0.89 (GM 22.49% / 25.15%) |
| AQI: 0.97 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 1.10 (Revenue 361b / 329b) |
| TATA: -0.06 (NI 32.8b - CFO 59.7b) / TA 464b) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of October 17, 2026, the stock is trading at USD 178.98 with a total of 13,186,630 shares traded. Over the past week, the price has changed by +5.94%, over one month by +9.59%, over three months by +23.43% and over the past year by +66.46%.
Current recommended Stop Loss: 173.80 (which is 2.9% or 1.5 ATR below the current price).
Exxon Mobil has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold XOM.
- StrongBuy: 6
- Buy: 3
- Hold: 16
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 173.6 | -3% |
P/E Trailing = 21.686
P/E Forward = 14.771
P/S = 1.919
P/B = 2.556
P/EG = 1.3811
Revenue TTM = 361b USD
EBIT TTM = 42.2b USD
EBITDA TTM = 71.8b USD
Long Term Debt = 32.2b USD (from longTermDebt, last quarter)
Short Term Debt = 10.1b USD (from shortTermDebt, last quarter)
Debt = 48.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 6.31b
Net Debt = 38.1b USD (calculated: Debt 48.7b - CCE 10.6b)
Enterprise Value = 731b USD (693b + Debt 48.7b - CCE 10.6b)
Interest Coverage Ratio = 52.13 (Ebit TTM 42.2b / Interest Expense TTM 809.0m)
EV/FCF = 23.92x (Enterprise Value 731b / FCF TTM 30.6b)
FCF Yield = 4.18% (FCF TTM 30.6b / Enterprise Value 731b)
FCF Margin = 8.46% (FCF TTM 30.6b / Revenue TTM 361b)
Net Margin = 9.07% (Net Income TTM 32.8b / Revenue TTM 361b)
Gross Margin = 25.15% ((Revenue TTM 361b - Cost of Revenue TTM 270b) / Revenue TTM)
Gross Margin QoQ = 22.38% (prev 37.71%)
Tobins Q-Ratio = 1.57 (Enterprise Value 731b / Total Assets 464b)
Interest Expense / Debt = 1.66% (Interest Expense 809.0m / Debt 48.7b)
Taxrate = 25.63% (11.6b / 45.4b)
NOPAT = 31.4b (EBIT 42.2b * (1 - 25.63%))
Current Ratio = 1.13 (Total Current Assets 101b / Total Current Liabilities 88.8b)
Debt / Equity = 0.19 (Debt 48.7b / totalStockholderEquity, last quarter 259b)
Debt / EBITDA = 0.53 (Net Debt 38.1b / EBITDA 71.8b)
Debt / FCF = 1.25 (Net Debt 38.1b / FCF TTM 30.6b)
Total Stockholder Equity = 258b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.18% (Net Income 32.8b / Total Assets 464b)
RoE = 12.68% (Net Income TTM 32.8b / Total Stockholder Equity 258b)
RoCE = 14.51% (EBIT 42.2b / Capital Employed (Equity 258b + L.T.Debt 32.2b))
RoIC = 8.36% (NOPAT 31.4b / Invested Capital 375b)
WACC = 5.58% (E(693b)/V(742b) * Re(5.89%) + D(48.7b)/V(742b) * Rd(1.66%) * (1-Tc(0.26)))
Discount Rate = 5.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -12.12 | Cagr: 1.93%
[DCF] Terminal Value 76.07% ; FCFF base≈30.0b ; Y1≈31.3b ; Y5≈36.0b
[DCF] Fair Price = 125.6 (EV 555b - Net Debt 38.1b = Equity 516b / Shares 4.11b; r=8.35% [WACC [floored]]; 5y FCF grow 4.91% → 2.50% )
EPS Correlation: -82.38 | EPS CAGR: -12.62% | SUE: -3.20 | # QB: -1
Revenue Correlation: -10.72 | Revenue CAGR: -0.37% | SUE: 3.65 | # QB: 1
EPS current Quarter (2026-09-30): EPS=3.76 | Chg30d=+4.91% | Revisions=+50% | Analysts=17
EPS current Year (2026-12-31): EPS=12.46 | Chg30d=+6.25% | Revisions=+67% | GrowthEPS=+78.3% | GrowthRev=+25.1%
EPS next Year (2027-12-31): EPS=11.39 | Chg30d=+5.98% | Revisions=+30% | GrowthEPS=-8.6% | GrowthRev=-0.0%
[Analyst] Revisions Ratio: +63% (up=14, down=2)